A molecular basis for nicotine as a gateway drug

New England Journal of Medicine

Volumn 371, Issue 21, 2014, Pages 2038-2039

  Rosenberg, Jacob M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; MOLECULAR MARKER; NICOTINE;

BEHAVIOR; BIOCHEMISTRY; COCAINE DEPENDENCE; EFFECT SIZE; HUMAN; LETTER; NONHUMAN; SOCIAL ASPECT; TOBACCO USE; ANIMAL; BRAIN; DRUG EFFECTS; LONG TERM MEMORY; METABOLISM; PHYSIOLOGY; SUBSTANCE-RELATED DISORDERS; CORRELATION ANALYSIS; DRUG USE; INCIDENCE; PREDICTION; SMOKING; UNITED STATES;

ANIMALS; BRAIN; COCAINE; HUMANS; MEMORY, LONG-TERM; NICOTINE; SUBSTANCE-RELATED DISORDERS;

EID: 84911427973     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1411785     Document Type: Letter

References (2)

1. Kandel ER, Kandel DB. Shattuck Lecture: a molecular basis for nicotine as a gateway drug. N Engl J Med 2014;371:932-43.
2. Smokefree and tobacco-free U.S. and tribal colleges and universities. Berkeley, CA: American Nonsmokers' Rights Foundation, 2014 (http://no-smoke.org/pdf/smokefreecollegesuniversities.pdf).